006620 — DongKoo Bio & Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual cashflow statement for DongKoo Bio & Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	15,101	9,140	9,327	6,614	11,808
Depreciation
Amortisation
Non-Cash Items	-6,540	1,481	2,705	11,644	5,412
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,054	-7,638	818	-7,072	-19,663
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	10,139	7,489	17,903	16,819	3,585
Capital Expenditures	-8,770	-5,461	-5,475	-11,075	-15,965
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,456	-7,103	5,939	-15,938	10,832
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-11,225	-12,564	464	-27,014	-5,133
Financing Cash Flow Items	—	—	-76.1	-50	49
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6,715	-361	-3,688	3,185	4,752
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	5,610	-5,460	14,676	-7,043	3,199